Cargando…

Designer genetically encoded voltage‐dependent calcium channel inhibitors inspired by RGK GTPases

High‐voltage‐activated calcium (Ca(V)1/Ca(V)2) channels translate action potentials into Ca(2+) influx in excitable cells to control essential biological processes that include; muscle contraction, synaptic transmission, hormone secretion and activity‐dependent regulation of gene expression. Modulat...

Descripción completa

Detalles Bibliográficos
Autor principal: Colecraft, Henry M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195252/
https://www.ncbi.nlm.nih.gov/pubmed/32104913
http://dx.doi.org/10.1113/JP276544
_version_ 1783528495573368832
author Colecraft, Henry M.
author_facet Colecraft, Henry M.
author_sort Colecraft, Henry M.
collection PubMed
description High‐voltage‐activated calcium (Ca(V)1/Ca(V)2) channels translate action potentials into Ca(2+) influx in excitable cells to control essential biological processes that include; muscle contraction, synaptic transmission, hormone secretion and activity‐dependent regulation of gene expression. Modulation of Ca(V)1/Ca(V)2 channel activity is a powerful mechanism to regulate physiology, and there are a host of intracellular signalling molecules that tune different aspects of Ca(V) channel trafficking and gating for this purpose. Beyond normal physiological regulation, the diverse Ca(V) channel modulatory mechanisms may potentially be co‐opted or interfered with for therapeutic benefits. Ca(V)1/Ca(V)2 channels are potently inhibited by a four‐member sub‐family of Ras‐like GTPases known as RGK (Rad, Rem, Rem2, Gem/Kir) proteins. Understanding the mechanisms by which RGK proteins inhibit Ca(V)1/Ca(V)2 channels has led to the development of novel genetically encoded Ca(V) channel blockers with unique properties; including, chemo‐ and optogenetic control of channel activity, and blocking channels either on the basis of their subcellular localization or by targeting an auxiliary subunit. These genetically encoded Ca(V) channel inhibitors have outstanding utility as enabling research tools and potential therapeutics. [Image: see text]
format Online
Article
Text
id pubmed-7195252
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71952522020-09-25 Designer genetically encoded voltage‐dependent calcium channel inhibitors inspired by RGK GTPases Colecraft, Henry M. J Physiol Symposium reviews High‐voltage‐activated calcium (Ca(V)1/Ca(V)2) channels translate action potentials into Ca(2+) influx in excitable cells to control essential biological processes that include; muscle contraction, synaptic transmission, hormone secretion and activity‐dependent regulation of gene expression. Modulation of Ca(V)1/Ca(V)2 channel activity is a powerful mechanism to regulate physiology, and there are a host of intracellular signalling molecules that tune different aspects of Ca(V) channel trafficking and gating for this purpose. Beyond normal physiological regulation, the diverse Ca(V) channel modulatory mechanisms may potentially be co‐opted or interfered with for therapeutic benefits. Ca(V)1/Ca(V)2 channels are potently inhibited by a four‐member sub‐family of Ras‐like GTPases known as RGK (Rad, Rem, Rem2, Gem/Kir) proteins. Understanding the mechanisms by which RGK proteins inhibit Ca(V)1/Ca(V)2 channels has led to the development of novel genetically encoded Ca(V) channel blockers with unique properties; including, chemo‐ and optogenetic control of channel activity, and blocking channels either on the basis of their subcellular localization or by targeting an auxiliary subunit. These genetically encoded Ca(V) channel inhibitors have outstanding utility as enabling research tools and potential therapeutics. [Image: see text] John Wiley and Sons Inc. 2020-04-21 2020-05-01 /pmc/articles/PMC7195252/ /pubmed/32104913 http://dx.doi.org/10.1113/JP276544 Text en © 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symposium reviews
Colecraft, Henry M.
Designer genetically encoded voltage‐dependent calcium channel inhibitors inspired by RGK GTPases
title Designer genetically encoded voltage‐dependent calcium channel inhibitors inspired by RGK GTPases
title_full Designer genetically encoded voltage‐dependent calcium channel inhibitors inspired by RGK GTPases
title_fullStr Designer genetically encoded voltage‐dependent calcium channel inhibitors inspired by RGK GTPases
title_full_unstemmed Designer genetically encoded voltage‐dependent calcium channel inhibitors inspired by RGK GTPases
title_short Designer genetically encoded voltage‐dependent calcium channel inhibitors inspired by RGK GTPases
title_sort designer genetically encoded voltage‐dependent calcium channel inhibitors inspired by rgk gtpases
topic Symposium reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195252/
https://www.ncbi.nlm.nih.gov/pubmed/32104913
http://dx.doi.org/10.1113/JP276544
work_keys_str_mv AT colecrafthenrym designergeneticallyencodedvoltagedependentcalciumchannelinhibitorsinspiredbyrgkgtpases